Search results
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
Market Watch· 6 days agojumped more than 30% Monday morning after the health and wellness platform said it would offer...
Hims & Hers Will Offer Ozempic and Wegovy Alternative Weight-loss Medications That Cost Nearly 90...
WWD via Yahoo Finance· 5 days agoIn the event of shortages, the United States Food and Drug Administration allows certain...
Hims & Hers Will Sell Wegovy-Like Weight Loss Drugs for $199
Gizmodo via Yahoo Finance· 6 days agoThe millennial-skewed telehealth platform Hims & Hers announced Monday that is now offering...
Hims & Hers Is Selling Copycat Weight-Loss Drugs. Here’s How.
Barrons.com· 4 days agoA plan by Hims & Hers Health to sell legal copies of Novo Nordisk weight loss drug Wegovy is drawing...
Hims Debuts $199 Weight-Loss Shots at 85% Discount to Wegovy
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- In just a few years, Hims & Hers Health Inc. reached almost $1 billion in sales by...
Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.
CBS News· 6 days agoDirect-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1...
Hims & Hers is selling an Ozempic knockoff without FDA approval. Here's how
Quartz· 5 days agoThe millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in...
Hims & Hers Is Now Selling Semaglutide: Here's What You Should Know
Verywell Health via Yahoo Finance· 4 days agoThey also tend to have high price tags, leaving them out of reach for many. This week, telehealth...
Hims & Hers health PAO Irene Becklund sells $13,673 in stock By Investing.com
Investing.com· 6 days agoHims & Hers Health, Inc. (NYSE:HIMS) reported a significant transaction by PAO Irene Becklund,...
Hims & Hers shares maintain Hold on the expansion of weight loss program By Investing.com
Investing.com· 6 days agoOn Monday, Truist Securities maintained a Hold rating on shares of Hims & Hers Health, Inc. (NYSE:...